Cargando…
Zanubrutinib in patients with treatment‐naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded‐access study of 50 patients in the United States
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928654/ https://www.ncbi.nlm.nih.gov/pubmed/36819162 http://dx.doi.org/10.1002/jha2.619 |
| _version_ | 1784888689573232640 |
|---|---|
| author | Castillo, Jorge J Kingsley, Edwin C Narang, Mohit Yimer, Habte A Dasanu, Constantin A Melear, Jason M Coleman, Morton Farber, Charles M Shulman, Jonah Mantovani, Emily H Zhang, Xiaowei Cohen, Aileen Huang, Jane |
| author_facet | Castillo, Jorge J Kingsley, Edwin C Narang, Mohit Yimer, Habte A Dasanu, Constantin A Melear, Jason M Coleman, Morton Farber, Charles M Shulman, Jonah Mantovani, Emily H Zhang, Xiaowei Cohen, Aileen Huang, Jane |
| author_sort | Castillo, Jorge J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9928654 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99286542023-02-16 Zanubrutinib in patients with treatment‐naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded‐access study of 50 patients in the United States Castillo, Jorge J Kingsley, Edwin C Narang, Mohit Yimer, Habte A Dasanu, Constantin A Melear, Jason M Coleman, Morton Farber, Charles M Shulman, Jonah Mantovani, Emily H Zhang, Xiaowei Cohen, Aileen Huang, Jane EJHaem Correspondence John Wiley and Sons Inc. 2023-01-11 /pmc/articles/PMC9928654/ /pubmed/36819162 http://dx.doi.org/10.1002/jha2.619 Text en © 2022 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Correspondence Castillo, Jorge J Kingsley, Edwin C Narang, Mohit Yimer, Habte A Dasanu, Constantin A Melear, Jason M Coleman, Morton Farber, Charles M Shulman, Jonah Mantovani, Emily H Zhang, Xiaowei Cohen, Aileen Huang, Jane Zanubrutinib in patients with treatment‐naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded‐access study of 50 patients in the United States |
| title | Zanubrutinib in patients with treatment‐naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded‐access study of 50 patients in the United States |
| title_full | Zanubrutinib in patients with treatment‐naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded‐access study of 50 patients in the United States |
| title_fullStr | Zanubrutinib in patients with treatment‐naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded‐access study of 50 patients in the United States |
| title_full_unstemmed | Zanubrutinib in patients with treatment‐naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded‐access study of 50 patients in the United States |
| title_short | Zanubrutinib in patients with treatment‐naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded‐access study of 50 patients in the United States |
| title_sort | zanubrutinib in patients with treatment‐naïve or relapsed/refractory waldenström macroglobulinemia: an expanded‐access study of 50 patients in the united states |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928654/ https://www.ncbi.nlm.nih.gov/pubmed/36819162 http://dx.doi.org/10.1002/jha2.619 |
| work_keys_str_mv | AT castillojorgej zanubrutinibinpatientswithtreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemiaanexpandedaccessstudyof50patientsintheunitedstates AT kingsleyedwinc zanubrutinibinpatientswithtreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemiaanexpandedaccessstudyof50patientsintheunitedstates AT narangmohit zanubrutinibinpatientswithtreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemiaanexpandedaccessstudyof50patientsintheunitedstates AT yimerhabtea zanubrutinibinpatientswithtreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemiaanexpandedaccessstudyof50patientsintheunitedstates AT dasanuconstantina zanubrutinibinpatientswithtreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemiaanexpandedaccessstudyof50patientsintheunitedstates AT melearjasonm zanubrutinibinpatientswithtreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemiaanexpandedaccessstudyof50patientsintheunitedstates AT colemanmorton zanubrutinibinpatientswithtreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemiaanexpandedaccessstudyof50patientsintheunitedstates AT farbercharlesm zanubrutinibinpatientswithtreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemiaanexpandedaccessstudyof50patientsintheunitedstates AT shulmanjonah zanubrutinibinpatientswithtreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemiaanexpandedaccessstudyof50patientsintheunitedstates AT mantovaniemilyh zanubrutinibinpatientswithtreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemiaanexpandedaccessstudyof50patientsintheunitedstates AT zhangxiaowei zanubrutinibinpatientswithtreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemiaanexpandedaccessstudyof50patientsintheunitedstates AT cohenaileen zanubrutinibinpatientswithtreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemiaanexpandedaccessstudyof50patientsintheunitedstates AT huangjane zanubrutinibinpatientswithtreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemiaanexpandedaccessstudyof50patientsintheunitedstates |